These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26020629)

  • 1. Birth Weight Is Associated With the IGF-1 Response to GH in Children: Programming of the Anabolic Action of GH?
    Donzeau A; Bouhours-Nouet N; Fauchard M; Decrequy A; Mathieu E; Boux de Casson F; Gascoin G; Coutant R
    J Clin Endocrinol Metab; 2015 Aug; 100(8):2972-8. PubMed ID: 26020629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body composition, fasting leptin, and sex steroid administration determine GH sensitivity in peripubertal short children.
    Coutant R; Boux de Casson F; Rouleau S; Douay O; Mathieu E; Audran M; Limal JM
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5805-12. PubMed ID: 11739442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents.
    Coutant R; de Casson FB; Rouleau S; Douay O; Mathieu E; Gatelais F; Bouhours-Nouet N; Voinot C; Audran M; Limal JM
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6185-92. PubMed ID: 15579776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature.
    Bouhours-Nouet N; Gatelais F; Boux de Casson F; Rouleau S; Coutant R
    J Clin Endocrinol Metab; 2007 Feb; 92(2):629-35. PubMed ID: 17090643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone.
    de Waal WJ; Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Drop SL
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):621-30. PubMed ID: 7828352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the GH/IGF-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal boys.
    Guercio G; Rivarola MA; Chaler E; Maceiras M; Belgorosky A
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1162-9. PubMed ID: 11889181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth.
    Kajantie E; Fall CH; Seppälä M; Koistinen R; Dunkel L; Ylihärsilä H; Osmond C; Andersson S; Barker DJ; Forsén T; Holt RI; Phillips DI; Eriksson J
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1059-65. PubMed ID: 12629086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth.
    McIntyre HD; Serek R; Crane DI; Veveris-Lowe T; Parry A; Johnson S; Leung KC; Ho KK; Bougoussa M; Hennen G; Igout A; Chan FY; Cowley D; Cotterill A; Barnard R
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1143-50. PubMed ID: 10720053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pubertal alterations in growth and body composition. VI. Pubertal insulin resistance: relation to adiposity, body fat distribution and hormone release.
    Roemmich JN; Clark PA; Lusk M; Friel A; Weltman A; Epstein LH; Rogol AD
    Int J Obes Relat Metab Disord; 2002 May; 26(5):701-9. PubMed ID: 12032756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence.
    Löfqvist C; Andersson E; Gelander L; Rosberg S; Hulthen L; Blum WF; Wikland KA
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1420-7. PubMed ID: 15598696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. Swedish Study Group for Growth Hormone Treatment.
    Kriström B; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2889-98. PubMed ID: 9284715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GH sensitivity of GH-deficient adults is dependent on gender but not timing of onset.
    Columb B; Smethurst LE; Mukherjee A; Jostel A; Shalet SM; Murray RD
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):281-6. PubMed ID: 18702681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
    de Lind van Wijngaarden RF; Siemensma EP; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Bocca G; Houdijk EC; Hoorweg-Nijman JJ; Vreuls RC; Jira PE; van Trotsenburg AS; Bakker B; Schroor EJ; Pilon JW; Wit JM; Drop SL; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4205-15. PubMed ID: 19837938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factors and intrauterine growth retardation. II. Serum growth hormone, insulin-like growth factor (IGF) I, and IGF-binding protein 3 levels in children with intrauterine growth retardation compared with normal control subjects: prospective study from birth to two years of age. Study Group of IUGR.
    Leger J; Noel M; Limal JM; Czernichow P
    Pediatr Res; 1996 Jul; 40(1):101-7. PubMed ID: 8798254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-1 and growth response to adult height in a randomized GH treatment trial in short non-GH-deficient children.
    Kriström B; Lundberg E; Jonsson B; Albertsson-Wikland K;
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2917-24. PubMed ID: 24823461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity.
    Gleeson HK; Lissett CA; Shalet SM
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1061-7. PubMed ID: 15522943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
    Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.